Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Michael G. Case
Based on 13 articles published since 2010
(Why 13 articles?)
||||
Expertise Level
The expertise of Michael G. Case ranks in the
  • Top 3.4%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 13 articles on the topic.
Graphical view (beta)
Aliases Case, Michael G   ·   Case, M   ·   Case, M G   ·   Case, Michael
Work Locations
Details
Most likely:    Eli Lilly Corporation      
2019
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Erl Wood Manor, Surrey, UK. · Bioclinica, Newark, CA, USA. · Bioclinica, Lyon, France. · Avid Radiopharmaceuticals, Philadelphia, PA, USA. · Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Neurology Associates, Boston, MA, USA. · Pubmed 31388559
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Windlesham, UK. · Siemers Integration, LLC, Zionsville, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 30511011
2017
  • a Lilly Research Laboratories , Lilly Corporate Center, Indianapolis , Indiana , USA. · b Pentara Corporation , Salt Lake City , Utah , USA. · c Department of Neurology, University of Southern California , San Diego , California , USA. · Pubmed 28402165
2016
  • Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA. · Avid Radiopharmaceuticals, Philadelphia PA, USA. · Pubmed 26238576
  • Lilly Bio-medicines, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Neurology, CNS Medical Strategy & Science, Therapeutic Science & Strategy Unit, Quintiles, Durham, NC, USA. · Medical Imaging, Neuroscience, Bioclinica, Newark, CA, USA. · Medical Imaging, Neuroscience, Bioclinica, Newark, CA, USA; Department of Radiology, California Pacific Medical Center, San Francisco, CA, USA. · Pubmed 27239538
  • IU Health Physicians Group, Department of Psychiatry, Indiana University School of Medicine Collaboration, Indiana University Health, Indianapolis, IN. · Lilly USA, LLC, Neurosciences, Indianapolis, IN. · Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN. · Lilly USA, LLC, Neurosciences, Indianapolis, IN; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN. · Lilly USA, LLC, Neurosciences, Indianapolis, IN. Electronic address: · inVentiv Health, LLC, Burlington, MA. · Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 26892326
  • Eli Lilly and Company or a Wholly Owned subsidiary, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Indiana University Physician Group, Indiana University Health, Indianapolis, IN, USA. · Johns Hopkins University and Johns Hopkins Bayview, Baltimore, MD, USA. · Pubmed 26639960
2015
  • Eli Lilly and Company, Indianapolis, IN, USA; Department of Neurology Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Eli Lilly and Company, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana University Health Physicians Group, Indiana University Health, Indianapolis, IN, USA. · Pubmed 25916563
2018
  • Hong Liu-Seifert, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana , USA, , Phone: +1 3174330662. · Pubmed 29405226
2016
  • Helen Hochstetler, Lilly Corporate Center, Indianapolis, IN 46285; Phone: 317-433-3707; E-mail: · Pubmed 29210444
2014
  • Eli Lilly and Company, Indianapolis, IN, USA; Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: · Pubmed 23954175
Probable:    Indiana University Indianapolis   Contact    
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
2014
  • Eli Lilly and Company, Indianapolis, IN, USA; Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: · Pubmed 23954175
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by Michael G. Case about Alzheimer Disease:

  • Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's disease. 2019
  • Delayed-Start Analyses in the Phase 3 Solanezumab EXPEDITION3 Study in Mild Alzheimer's Disease. 2018
  • Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. 2018
  • Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia. 2018
  • Statistical properties of continuous composite scales and implications for drug development. 2017
  • Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. 2016
  • Longitudinal Trajectories of Clinical Decline in Amyloid Positive and Negative Populations. 2016
  • Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease. 2016
  • Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia. 2016
  • Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline. 2016
Show List of Full Article Records
Google Searches

Learn more about Michael G. Case using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Eli Lilly Corporation
Indiana University Indianapolis
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Eli Lilly Corporation
2019
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Erl Wood Manor, Surrey, UK. · Bioclinica, Newark, CA, USA. · Bioclinica, Lyon, France. · Avid Radiopharmaceuticals, Philadelphia, PA, USA. · Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Neurology Associates, Boston, MA, USA. · Pubmed 31388559
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Windlesham, UK. · Siemers Integration, LLC, Zionsville, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 30511011
2017
  • a Lilly Research Laboratories , Lilly Corporate Center, Indianapolis , Indiana , USA. · b Pentara Corporation , Salt Lake City , Utah , USA. · c Department of Neurology, University of Southern California , San Diego , California , USA. · Pubmed 28402165
2016
  • Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA. · Avid Radiopharmaceuticals, Philadelphia PA, USA. · Pubmed 26238576
  • Lilly Bio-medicines, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Neurology, CNS Medical Strategy & Science, Therapeutic Science & Strategy Unit, Quintiles, Durham, NC, USA. · Medical Imaging, Neuroscience, Bioclinica, Newark, CA, USA. · Medical Imaging, Neuroscience, Bioclinica, Newark, CA, USA; Department of Radiology, California Pacific Medical Center, San Francisco, CA, USA. · Pubmed 27239538
  • IU Health Physicians Group, Department of Psychiatry, Indiana University School of Medicine Collaboration, Indiana University Health, Indianapolis, IN. · Lilly USA, LLC, Neurosciences, Indianapolis, IN. · Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN. · Lilly USA, LLC, Neurosciences, Indianapolis, IN; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN. · Lilly USA, LLC, Neurosciences, Indianapolis, IN. Electronic address: · inVentiv Health, LLC, Burlington, MA. · Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 26892326
  • Eli Lilly and Company or a Wholly Owned subsidiary, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Indiana University Physician Group, Indiana University Health, Indianapolis, IN, USA. · Johns Hopkins University and Johns Hopkins Bayview, Baltimore, MD, USA. · Pubmed 26639960
2015
  • Eli Lilly and Company, Indianapolis, IN, USA; Department of Neurology Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Eli Lilly and Company, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana University Health Physicians Group, Indiana University Health, Indianapolis, IN, USA. · Pubmed 25916563
2018
  • Hong Liu-Seifert, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana , USA, , Phone: +1 3174330662. · Pubmed 29405226
2016
  • Helen Hochstetler, Lilly Corporate Center, Indianapolis, IN 46285; Phone: 317-433-3707; E-mail: · Pubmed 29210444
2014
  • Eli Lilly and Company, Indianapolis, IN, USA; Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: · Pubmed 23954175
Indiana University Indianapolis
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
2014
  • Eli Lilly and Company, Indianapolis, IN, USA; Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: · Pubmed 23954175
Yearly article counts 01315120000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.